The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Cynapsus Therapeutics Parkinson’s Disease Candidate Gets FDA Fast Track Designation


(August 31, 2016) - Cynapsus Therapeutics said its APL-130277 product candidate for the treatment of off-episodes in patients with Parkinson’s Disease has received fast track designation from the U.S. Food and Drug Administration (FDA). The company said its phase 3 clinical program for the treatment is nearing completion and that it plans to submit a new drug application to the FDA in the first half of 2017. Read more…



Article Archive

back